- CA$11.05m
- CA$29.19m
- CA$2.54m
Annual balance sheet for Pharmacielo, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 15 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.63 | 0.326 | 0.062 | 0.054 | 0.018 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.565 | 0.671 | 0.761 | 0.958 | 0.89 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 9.2 | 4.02 | 3.33 | 2.41 | 3.56 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 26.1 | 20.6 | 18.7 | 16.1 | 9.01 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 36 | 25.1 | 22.3 | 18.5 | 12.6 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.07 | 6.95 | 21.4 | 23.4 | 23.5 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 16.6 | 18.7 | 24 | 28 | 23.5 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 19.3 | 6.39 | -1.68 | -9.49 | -11 |
| Total Liabilities & Shareholders' Equity | 36 | 25.1 | 22.3 | 18.5 | 12.6 |
| Total Common Shares Outstanding |